Funding
None of the authors has a financial interest or commercial association to declare in relation to the content of this article.

References

1. Wiegand S, Berner R, Schneider A, Lundershausen E, Dietz A. Otitis externa. Dtsch Arztebl Int . 2019 Mar 29;116(13):224–34.
2. Roland PS, Stroman DW. Microbiology of Acute Otitis Externa.Laryngoscope . 2002 Jul;112(7):1166–77.
3. Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol . 2005 Nov; 69(11):1503–8.
4. Martinez Devesa P, Willis CM, Capper JWR. External auditory canal pH in chronic otitis externa. Clin Otolaryngol Allied Sci . 2003 Aug;28(4):320–4.
5. Mcshane D, Alun-Jones T, Walsh M. What causes acute otitis externa?J Laryngol Otol. 1993;107(10):898–901.
6. David O. Otitis Externa: Review and Clinical Update - American Family Physician. Am Fam Physician . 2006. p. 1;74(9):1510-1516.
7. Hajioff D, Mackeith S. Otitis externa. BMJ Clin Evid . 2008 Jun. pii: 0510.
8. Pabla L, Jindal M, Latif K. The management of otitis externa in UK general practice. Eur Arch Oto-Rhino-Laryngology . 2012;269(3):753–6.
9. Rowlands S, Devalia H, Smith C, Hubbard R, Dean A. Otitis externa in UK general practice: A survey using the UK General Practice Research Database. Br J Gen Pract . 2001; 51(468):533–8.
10. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Vol. 22, Clinical Microbiology Reviews . 2009. p. 582–610.
11. Rosenfeld RM, Schwartz SR, Cannon CR, Roland PS, Simon GR, Kumar KA, et al. Clinical Practice Guideline. Otolaryngol Neck Surg . 2014 Feb;150(suppl 1):S1–24.
12. Golder J. Oral steroids in the treatment of otitis externa.Aust Fam Physician . 1999 Aug;28(8):775.
13. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, et al. DrugBank 3.0: a comprehensive resource for “Omics” research on drugs. Nucleic Acids Res. 2011 Jan];39(Database):D1035–41.
14. Pérez Obón J, Rivares Esteban J, Leache Pueyo J, Fernández Liesa R, Marín García J, Sevil Navarro J, et al. [An outpatient study in ENT (otorhinolaryngology) emergencies at a general hospital]. Acta Otorrinolaringol Esp . 1995;46(4):298–304.
15. Centers for Disease Control and Prevention. Estimated burden of acute otitis externa—United States, 2003-2007. MMWR Morb Mortal Wkly Rep . 2011;60:605-609
16. van Asperen IA, de Rover CM, Schijven JF, Oetomo SB, Schellekens JF, van Leeuwen NJ, et al. Risk of otitis externa after swimming in recreational fresh water lakes containing Pseudomonas aeruginosa.BMJ . 1995 Nov 25 ;311(7017):1407–10.
17. Fishpool SJC, Stanton E, Chawishly EK, Hicklin LAC. Audit of frequent attendees to an ENT emergency clinic. J Laryngol Otol . 2009;123(11):1242–5.
18. Raza SA, Denholm SW, Wong JCH. An audit of the management of acute otitis externa in an ENT casualty clinic. J Laryngol Otol . 1995 Feb;109(2):130–3.
19. Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol . 2001;44(1 Suppl).
20. Caffier PP, Harth W, Mayelzadeh B, Haupt H, Scherer H, Sedlmaier B. Topical immunomodulation : A milestone for the treatment of therapy-resistant noninfectious chronic external otitis? HNO . 2008;56(5):530–7.
21. Montoro V, Asensio C, Martínez Á, Lorente J, Rodríguez FJ, Montojo J, et al. Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema: a randomized, double-blind, placebo-controlled clinical trial. J Int Med Res . 2018 Oct 1;46(10):4050–60.
22. Lingwood D, Simons K. Lipid Rafts As a Membrane-Organizing Principle. Science (80-). 2010 Jan;327(5961):46–50.
23. Kariuki BM, Psallidas K, Harris KDM, Johnston RL, Lancaster RW, Staniforth SE, et al. Structure determination of a steroid directly from powder diffraction data†. Chem Commun . 1999;(17):1677–8.
24. Crim C, Pierre LN, Daley-Yates PT. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. Clin Ther. 2001 Sep ;23(9):1339–54.

Tables and Charts

Chart I: Treatment modalities used before the Flixonase